Tirzepatide

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed to regulate blood sugar levels and enhance metabolic function. It is primarily used for the treatment of type 2 diabetes and weight management. By mimicking these incretin hormones, it improves insulin sensitivity, reduces glucagon secretion, and slows gastric emptying, leading to better glycemic control and appetite suppression. Tirzepatide is widely recognized for its effectiveness in supporting weight loss and managing obesity, making it a popular choice among individuals seeking metabolic health improvements. Its long-acting formula allows for convenient, once-weekly dosing, reducing the burden of daily medication while providing sustained benefits.